GO
Loading...

Gilead Sciences Inc

More

  • Final Glance: Biotechnology companies Monday, 20 Oct 2014 | 6:05 PM ET

    Amgen Inc. rose $3.82 or 2.9 percent, to $137.51. Biogen Idec rose $4.70 or 1.5 percent, to $311.41. Celgene Corp. rose $3.88 or 4.4 percent, to $92.00.

  • Midday Glance: Biotechnology companies Monday, 20 Oct 2014 | 1:23 PM ET

    Amgen Inc. rose$. 35 or. 3 percent, to $134.04. Biogen Idec rose $3.41 or 1.1 percent, to $310.12. Celgene Corp. rose $3.24 or 3.7 percent, to $91.36.

  • Early Glance: Biotechnology companies Monday, 20 Oct 2014 | 10:40 AM ET

    Amgen Inc. rose$. 93 or. 7 percent, to $134.62. Biogen Idec rose $2.07 or. 7 percent, to $308.78. Celgene Corp. rose $1.72 or 2.0 percent, to $89.84.

  • Final Glance: Biotechnology companies Friday, 17 Oct 2014 | 6:03 PM ET

    Amgen Inc. rose $3.24 or 2.5 percent, to $133.69. Biogen Idec rose $3.97 or 1.3 percent, to $306.71. Celgene Corp. rose $1.74 or 2.0 percent, to $88.12.

  • Midday Glance: Biotechnology companies Friday, 17 Oct 2014 | 1:21 PM ET

    Amgen Inc. rose $3.30 or 2.5 percent, to $133.75. Biogen Idec rose $9.17 or 3.0 percent, to $311.91. Celgene Corp. rose $3.04 or 3.5 percent, to $89.42.

  • Early Glance: Biotechnology companies Friday, 17 Oct 2014 | 10:39 AM ET

    Amgen Inc. rose$. 25 or. 2 percent, to $130.70. Biogen Idec rose $8.00 or 2.6 percent, to $310.74. Celgene Corp. rose $2.45 or 2.8 percent, to $88.83.

  • Final Glance: Biotechnology companies Thursday, 16 Oct 2014 | 6:02 PM ET

    Amgen Inc. fell$. 45 or. 3 percent, to $130.45. Biogen Idec fell $2.95 or 1.0 percent, to $302.74. Celgene Corp. fell$. 17 or. 2 percent, to $86.38.

  • Midday Glance: Biotechnology companies Thursday, 16 Oct 2014 | 1:21 PM ET

    Amgen Inc. fell $1.85 or 1.4 percent, to $129.05. Biogen Idec fell $2.23 or. 7 percent, to $303.46. Celgene Corp. fell$. 18 or. 2 percent, to $86.37.

  • Early Glance: Biotechnology companies Thursday, 16 Oct 2014 | 11:35 AM ET

    Amgen Inc. fell $1.81 or 1.4 percent, to $129.09. Biogen Idec fell $2.69 or. 9 percent, to $303.00. Celgene Corp. fell $1.56 or 1.8 percent, to $84.99.

  • BOSTON, Oct 16- Some of Wall Street's biggest names are licking their wounds as October lives up to its reputation as one of the market's roughest months. Morgan Stanley strategists said this week that their model portfolio through Monday had trailed the S&P by 3.6 percentage points due to bad bets on technology stocks, including GT Advanced Technologies, the...

  • Final Glance: Biotechnology companies Wednesday, 15 Oct 2014 | 6:07 PM ET

    Amgen Inc. fell $1.30 or 1.0 percent, to $130.90. Biogen Idec rose $4.11 or 1.4 percent, to $305.69. Celgene Corp. rose$. 07 or. 1 percent, to $86.55.

  • The first, Esbriet, was developed by InterMune Inc, which Switzerland- based Roche Holding AG agreed to buy for $8.3 billion in August, banking largely on the treatment's potential. The agency's decision marks a crucial milestone in the management of the disease, which affects about 100,000 people in the United States. Roche's drug, known generically as...

  • Midday Glance: Biotechnology companies Wednesday, 15 Oct 2014 | 1:17 PM ET

    Amgen Inc. fell $2.15 or 1.6 percent, to $130.05. Biogen Idec rose $5.29 or 1.8 percent, to $306.87. Celgene Corp. fell $1.36 or 1.6 percent, to $85.12.

  • Early Glance: Biotechnology companies Wednesday, 15 Oct 2014 | 10:46 AM ET

    Amgen Inc. fell $1.56 or 1.2 percent, to $130.64. Biogen Idec rose $1.69 or. 6 percent, to $303.27. Celgene Corp. fell$. 90 or 1.0 percent, to $85.58.

  • Final Glance: Biotechnology companies Tuesday, 14 Oct 2014 | 6:03 PM ET

    Amgen Inc. fell $1.36 or 1.0 percent, to $132.20. Biogen Idec fell$. 16 or. 1 percent, to $301.58. Celgene Corp. fell $1.00 or 1.1 percent, to $86.48.

  • Citigroup and Domino's are big market movers Tuesday, 14 Oct 2014 | 4:37 PM ET

    NEW YORK— Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:. Johnson& Johnson, down $2.11 to $97.01. Citigroup Inc., up $1.57 to $51.47.

  • Midday Glance: Biotechnology companies Tuesday, 14 Oct 2014 | 1:42 PM ET

    Amgen Inc. fell$. 09 or. 1 percent, to $133.47. Biogen Idec rose $3.62 or 1.2 percent, to $305.36. Celgene Corp. rose$. 66 or. 8 percent, to $88.14.

  • Irish tax changes may cost U.S. groups billions Tuesday, 14 Oct 2014 | 11:15 AM ET

    *Brussels investigating schemes involving minimal tax. LONDON, Oct 14- Ireland's plan to close a "Double Irish" tax loophole could cost U.S. companies including Apple and Google billions of dollars, although a new break and pressure to tackle tax avoidance elsewhere means they are unlikely to decamp. Ireland has been an attractive base for U.S. multinationals for...

  • Early Glance: Biotechnology companies Tuesday, 14 Oct 2014 | 10:27 AM ET

    Amgen Inc. fell$. 92 or. 7 percent, to $132.64. Biogen Idec fell $5.23 or 1.7 percent, to $296.51. Celgene Corp. fell $1.41 or 1.6 percent, to $86.07.

  • *JPMorgan falls, Citigroup climbs after results. Citigroup, up 3.2 percent to $51.48, was the biggest boost to the benchmark S&P index after the bank posted better-than-expected quarterly results and said it would pull out of consumer banking in 11 markets. But JPMorgan Chase shares lost 0.9 percent to $57.61, after the biggest U.S. bank posted third-quarter...